EUVIMEDEUVIMED entdecken
Crossref

YTHDC1 inhibits osteoclast differentiation to alleviate osteoporosis by enhancing PTPN6 messenger RNA stability in an m6A-hUR–dependent manner

Meijie Zhang, Jiaxin Guan, Simiao Yu, Yimeng Zhang, Luyang Cheng, Yina Zhang

Journal of Leukocyte Biology · 29.05.2024 · 115 (6) · 1154-1164

DOI: 10.1093/jleuko/qiae021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Leukocyte Biology, online erschienen am 30.01.2024. Verfasst von Meijie Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, The Second Affiliated Hospital of Harbin Medical University, Nangang District, Harbin City, Heilongjiang Province, 150001, …. Hauptthemen laut MEDLINE: Cell Differentiation, Osteoclasts, Osteoporosis, RNA Stability. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Joint Guidance Project of Heilongjiang Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

YTHDC1 has been confirmed to mediate osteoporosis (OP) progression by regulating osteogenic differentiation. However, whether YTHDC1 mediates osteoclast differentiation and its molecular mechanism remains unclear. Quantitative real-time polymerase chain reaction and Western blot analysis were performed to detect the levels of YTHDC1, PTPN6, NFATc1, TRAP, RUNX2, alkaline phosphatase, and HUR. YTHDC1 knockout mice was constructed by CRISPR/Cas9 system, and the OP mice model was established by ovariectomy. Hematoxylin and eosin staining and micro-computed tomography were used to evaluate bone formation and bone mass. Mouse primary bone marrow macrophage cells were isolated and induced into osteoclasts. TRAP-positive cells were detected using TRAP staining. MeRIP-qPCR, RIP-qPCR assay, RNA affinity isolation assay, and co-immunoprecipitation assay were used to confirm the interactions among YTHDC1, PTPN6, and HUR. YTHDC1 expression was reduced and positively correlated with lumbar bone mineral density in OP patients. In the ovariectomy model of YTHDC1 knockout mice, bone formation was reduced, bone histomorphology was changed, and osteoclastic-related factor (NFATc1 and TRAP) levels were enhanced. Overexpression YTHDC1 inhibited osteoclast differentiation. YTHDC1 increased PTPN6 messenger RNA stability in an m6A-dependent manner. Moreover, YTHDC1 interacted with HUR to positively regulate PTPN6 expression. PTPN6 knockdown promoted osteoclast differentiation, and this effect was reversed by overexpressing HUR or YTHDC1. YTHDC1 was involved in regulating OP progression through inhibiting osteoclast differentiation by enhancing PTPN6 messenger RNA stability in an m6A-HUR–dependent manner.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell DifferentiationOsteoclastsOsteoporosisRNA StabilityRNA, MessengerProtein Tyrosine Phosphatase, Non-Receptor Type 6RNA Splicing FactorsAnimalsFemaleHumansMiceAdenosineDisease Models, AnimalELAV-Like Protein 1Mice, KnockoutOsteogenesisOvariectomyNerve Tissue Proteins

Stichwörter der Autor:innen

HURPTPN6YTHDC1m6Aosteoclast differentiationosteoporosis

Substanzen

AdenosineELAV-Like Protein 1Elavl1 protein, mouseN-methyladenosineRNA, MessengerYTHDC1 protein, humanPTPN6 protein, humanPtpn6 protein, mouseProtein Tyrosine Phosphatase, Non-Receptor Type 6RNA Splicing Factors

Autor:innen und Institutionen

  • Department of Geriatrics, The Second Affiliated Hospital of Harbin Medical University, Nangang District, Harbin City, Heilongjiang Province, 150001, P.R. China.

Förderung

  • Joint Guidance Project of Heilongjiang Provincial Natural Science Foundation

Zitieren

APA

Zhang, M., Guan, J., Yu, S., Zhang, Y., Cheng, L., & Zhang, Y. (2024). YTHDC1 inhibits osteoclast differentiation to alleviate osteoporosis by enhancing PTPN6 messenger RNA stability in an m6A-hUR–dependent manner. Journal of Leukocyte Biology, 115(6), 1154-1164. https://doi.org/10.1093/jleuko/qiae021

Vancouver

Zhang M, Guan J, Yu S, Zhang Y, Cheng L, Zhang Y. YTHDC1 inhibits osteoclast differentiation to alleviate osteoporosis by enhancing PTPN6 messenger RNA stability in an m6A-hUR–dependent manner. Journal of Leukocyte Biology. 2024;115(6):1154-1164. doi:10.1093/jleuko/qiae021

BibTeX
@article{Zhang2024,
  author = {Zhang, Meijie and Guan, Jiaxin and Yu, Simiao and Zhang, Yimeng and Cheng, Luyang and Zhang, Yina},
  title = {YTHDC1 inhibits osteoclast differentiation to alleviate osteoporosis by enhancing PTPN6 messenger RNA stability in an m6A-hUR–dependent manner},
  journal = {Journal of Leukocyte Biology},
  year = {2024},
  volume = {115},
  number = {6},
  pages = {1154--1164},
  doi = {10.1093/jleuko/qiae021}
}
Kostenlos starten →